These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15636193)

  • 21. Is obstructive sleep apnea syndrome a neurological disorder? A continuous positive airway pressure follow-up study.
    Guilleminault C; Huang YS; Kirisoglu C; Chan A
    Ann Neurol; 2005 Dec; 58(6):880-7. PubMed ID: 16240364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous positive airway pressure treatment with nasal pillows in obstructive sleep apnea: long-term effectiveness and adherence.
    Lanza A; Mariani S; Sommariva M; Campana C; Rubino A; Nichelatti M; Proserpio P; Nobili L
    Sleep Med; 2018 Jan; 41():94-99. PubMed ID: 29196149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does nasal congestion have a role in decreased resistance to regular CPAP usage?
    İriz A; Düzlü M; Köktürk O; Kemaloğlu YK; Eravcı FC; Zorlu ME; Karamert R
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4031-4034. PubMed ID: 28921034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure.
    Banerjee D; Yee BJ; Piper AJ; Zwillich CW; Grunstein RR
    Chest; 2007 Jun; 131(6):1678-84. PubMed ID: 17565018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral continuous positive airway pressure for sleep apnea: effectiveness, patient preference, and adherence.
    Beecroft J; Zanon S; Lukic D; Hanly P
    Chest; 2003 Dec; 124(6):2200-8. PubMed ID: 14665501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nasal CPAP on exhaled SIRT1 and tumor necrosis factor-α in patients with obstructive sleep apnea.
    Lin CC; Liaw SF; Chiu CH; Chen WJ; Lin MW; Chang FT
    Respir Physiol Neurobiol; 2016 Jul; 228():39-46. PubMed ID: 26976689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with continuous positive airway pressure may affect blood glucose levels in nondiabetic patients with obstructive sleep apnea syndrome.
    Czupryniak L; Loba J; Pawlowski M; Nowak D; Bialasiewicz P
    Sleep; 2005 May; 28(5):601-3. PubMed ID: 16171273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of treatment by nasal continuous positive airway pressure on serum high mobility group box-1 protein in obstructive sleep apnea.
    Wu KM; Lin CC; Chiu CH; Liaw SF
    Chest; 2010 Feb; 137(2):303-9. PubMed ID: 19933373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resting energy expenditure in OSAS: the impact of a single CPAP application.
    Fekete K; Boutou AK; Pitsiou G; Chavouzis N; Pataka A; Athanasiou I; Ilonidis G; Kontakiotis T; Argyropoulou P; Kioumis I
    Sleep Breath; 2016 Mar; 20(1):121-8. PubMed ID: 25971739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of treatment with continuous positive airway pressure on respiratory muscle function and physical fitness in patients with obstructive sleep apnoea and overlap syndrome].
    Nowiński A; Bieleń P; Jonczak L; Sliwiński P
    Pneumonol Alergol Pol; 2007; 75(1):46-56. PubMed ID: 17541912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome.
    Hui DS; Ko FW; Fok JP; Chan MC; Li TS; Tomlinson B; Cheng G
    Chest; 2004 May; 125(5):1768-75. PubMed ID: 15136389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome.
    Noda A; Nakata S; Koike Y; Miyata S; Kitaichi K; Nishizawa T; Nagata K; Yasuma F; Murohara T; Yokota M
    Hypertens Res; 2007 Aug; 30(8):669-76. PubMed ID: 17917313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of three month nasal continuous positive airway pressure treatment on electrocardiographic, echocardiographic and overnight polysomnographic parameters in newly diagnosed moderate/severe obstructive sleep apnea patients.
    Cicek D; Balcioğlu AS; Lakadamyali H; Müderrisoğlu H
    Int Heart J; 2015; 56(1):94-9. PubMed ID: 25503651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study.
    Hall AB; Ziadi MC; Leech JA; Chen SY; Burwash IG; Renaud J; deKemp RA; Haddad H; Mielniczuk LM; Yoshinaga K; Guo A; Chen L; Walter O; Garrard L; DaSilva JN; Floras JS; Beanlands RS
    Circulation; 2014 Sep; 130(11):892-901. PubMed ID: 24993098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of continuous positive airway pressure on exercise capacity in chronic heart failure patients without sleep apnea.
    Steiner S; Schueller PO; Schannwell CM; Hennersdorf M; Strauer BE
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):665-72. PubMed ID: 18204181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome.
    Sanner BM; Tepel M; Markmann A; Zidek W
    Am J Hypertens; 2002 Mar; 15(3):251-7. PubMed ID: 11939616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment.
    Gonçalves MA; Guilleminault C; Ramos E; Palha A; Paiva T
    Sleep Med; 2005 Jul; 6(4):333-9. PubMed ID: 15946896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal resistance for determinant factor of nasal surgery in CPAP failure patients with obstructive sleep apnea syndrome.
    Nakata S; Noda A; Yagi H; Yanagi E; Mimura T; Okada T; Misawa H; Nakashima T
    Rhinology; 2005 Dec; 43(4):296-9. PubMed ID: 16405275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines.
    Sukegawa M; Noda A; Sugiura T; Nakata S; Yoshizaki S; Soga T; Yasuda Y; Iwayama N; Nakai S; Koike Y
    Clin Cardiol; 2005 Nov; 28(11):519-22. PubMed ID: 16450795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acoustic reflection for nasal airway measurement in patients with obstructive sleep apnea-hypopnea syndrome.
    Li HY; Engleman H; Hsu CY; Izci B; Vennelle M; Cross M; Douglas NJ
    Sleep; 2005 Dec; 28(12):1554-9. PubMed ID: 16408415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.